Back to CONGRESS ASSET MANAGEMENT CO CONGRESS ASSET MANAGEMENT CO

LGNDLGND
18 quarters

Position history for CONGRESS ASSET MANAGEMENT COCONGRESS ASSET MANAGEMENT CO's holdings in LIGAND PHARMACEUTICALS INC

Yes. Congress Asset Management holds 658,556 shares of LGND (Ligand Pharmaceuticals), worth $205.7M, as of its Q3 2026 13F filing. It reduced the position by 1,355 shares (-0.2%) from Q2 2026. Congress Asset Management has held LGND since Q2 2024, across 10 quarterly 13F filings. LGND is 1.3% of Congress Asset Management's reported 13F portfolio.

Current Value

$205.7M

Current Shares

658,556

Total Value Change

+$202.9M

Total Shares Change

+636,205

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
658,556
-0.2%
$205.7M1.3%$312.37
0
2026-Q2
Increased
659,911
+30.8%
$208.6M1.3%$316.09
61
2026-Q1
Increased
504,637
+5.1%
$100.8M0.7%$199.65
44
2025-Q4
Decreased
480,063
-28.1%
$90.8M0.6%$189.07
0
2025-Q3
Increased
667,311
+3.0%
$118.2M0.8%$177.14
44
2025-Q2
Increased
647,941
+0.8%
$73.7M0.5%$113.68
42
2025-Q1
Increased
642,712
+3.4%
$67.6M0.5%$105.14
43
2024-Q4
Increased
621,482
+2.9%
$66.6M0.5%$107.15
36
2024-Q3
Increased
604,038
+3.0%
$60.5M0.4%$100.09
36
2024-Q2
New
586,624
-
$49.4M0.4%$84.26
48
2020-Q4
Exited
0
-100.0%
$00.0%$62.04
0
2020-Q3
Increased
32,375
+4.6%
$3.1M0.0%$59.46
28
2020-Q2
Increased
30,947
+2.2%
$3.5M0.0%$69.78
27
2020-Q1
Increased
30,292
+58.8%
$2.2M0.0%$45.36
37
2019-Q4
Decreased
19,079
-25.4%
$2M0.0%$65.06
0
2019-Q3
Increased
25,563
+6.7%
$2.5M0.0%$62.10
28
2019-Q2
Increased
23,966
+7.2%
$2.7M0.0%$71.21
28
2019-Q1
First report
22,351
-
$2.8M0.0%$78.42
0

Other major holders of LGND: BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used